top of page
Drug and Syringe


The ADVANCE-VAC4PM project brings together a multidisciplinary consortium of ten leading institutions from Europe and Africa with complementary expertise and proven track records in malaria vaccine research and development, including research organizations, universities, one SME and one product development partnership (PDP).

The coordination and management of the ADVANCE-VAC4PM project is assured by the European Vaccine Initiative (EVI), Germany and the Project Steering Committee (PSC). To increase the chance of success towards the set objectives, the consortium is supported by a Scientific and Ethics Advisory Committee (SEAC) that will provide strategic inputs into scientific-technical, public health and ethical issues.

AdvanceVac4PM KoM.png

Participants at the ADVANCE-VAC4PM kick off meeting, 28-29 June 2022, Heidelberg, Germany

bottom of page